Patients · Physicians · Rare disease foundations
Orphan Drug & Rare Disease Supply
Rare disease therapies are often approved in only a handful of markets. We connect patients and physicians to orphan drugs through Named Patient Programmes, compassionate use and special access schemes — with the regulatory paperwork handled end-to-end.
What we support
- Global sourcing of orphan-designated and hard-to-access medicines
- Named Patient and compassionate use pathway support
- Physician documentation assistance (letters of justification, permits)
- Cold chain handling for biologics and enzyme therapies
- Case-managed by a dedicated coordinator
How the request works
- 1. Case Assessment
Tell us the medicine, the patient's country and the treating physician's details.
- 2. Pathway Identification
We identify the legal access route — NPP, compassionate use or special access scheme.
- 3. Permits & Sourcing
Destination-specific permit requirements and licensed-source feasibility are reviewed per case.
- 4. Delivery to Patient/Hospital
Temperature-controlled delivery with permit documentation for customs.